{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A multi-centric, cross-sectional, observational survey study to understand the role of combination of astaxanthin, lutein, zeaxanthin, DHA, vitamins and minerals (New I-Site plus tablet) in Diabetic Retinopathy

  1. How many years have you been practicing ophthalmology? *

  2. As per your clinical practice, what is the approximate number of patients with diabetic retinopathy (DR) present to you in your practice every month? *

  3. What is the approximate percentage of DR patients with co-morbidities, as per observations in your practice? (Please tick the applicable option) *

  4. Kindly rank the most common co-morbidities observed in DR patients as per your practice? (Please rank from rank 1 to rank 5 as from most common to least common comorbidity) *

  5. Do you routinely recommend antioxidant and micronutrient supplementation for patients with DR? *

  6. Which specific antioxidants and micronutrients do you commonly recommend for DR management? (Select all that apply) *

  7. How do you assess the effectiveness of antioxidant and micronutrient supplementation in DR management? *

  8. How frequently do you recommend follow-up visits for patients using antioxidant and micronutrient supplementation for DR management? *

  9. What are the key benefits or expected outcomes of antioxidant and micronutrient supplementation in DR management, based on your experience? (Select all that apply) *

  10. Are there any specific patient factors or conditions that require special considerations in recommending antioxidant and micronutrient supplementation for DR management? (Select all that apply) *

  11. How do you recommend New I Site plus tablet - a combination of Astaxanthin, lutein, zeaxanthin, vitamins and minerals to your patients with DR? *

  12. What are the primary reasons for prescribing a combination of astaxanthin, lutein, zeaxanthin, DHA, vitamins and minerals to your patients with DR ? (Select all that apply)? *

  13. How would you rate the efficacy of New I Site plus tablet - a combination of astaxanthin, lutein, zeaxanthin, DHA, vitamins and minerals in your patients with DR in terms of slowing the progression of DR? (Please tick the applicable option) *

  14. How would you rate New I Site plus tablet - a combination of astaxanthin, lutein, zeaxanthin, DHA, vitamins and minerals in your patients with DR in terms of compliance in patients? (Please tick the applicable option) *

  15. For what duration do you usually prescribe New I Site plus tablet - a combination of astaxanthin, lutein, zeaxanthin, DHA, vitamins and minerals in your patients with DR? (Select all that apply) *